Navigation Links
Pharmasset Initiates Phase 2b Clinical Trial of PSI-7977 for Chronic Hepatitis C Genotypes 1, 2, and 3
Date:8/24/2010

has recently initiated 12 weeks of dosing in a Phase 2b study, and PSI-938, an unpartnered guanosine nucleotide analog in a Phase 1 study. We also have in our pipeline an additional purine nucleotide analog, PSI-661, in advanced preclinical development. Racivir, for the treatment of HIV, has completed a Phase 2 clinical study.

Pegasys® and Copegus® are registered trademarks of Roche.ContactRichard E. T. Smith, Ph.D. VP, Investor Relations and Corporate Communicationsrichard.smith@pharmasset.comOffice: +1 (609) 613-4181Forward-Looking StatementsPharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:  Statements in this press release that are not historical facts are "forward-looking statements," including, without limitation, statements  that involve risks, uncertainties, and other important factors, including, without limitation,  the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates,  the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized.  For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2009 and our Quarterly Reports on Form 10-Q for the periods ended December 31, 2009, March 31, 2010 and June 30, 2010 filed with the Securities and Exchange Commission and disc
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014  Kindred Hospital Houston Northwest, with Wound ... of its new outpatient wound healing center.  The ... with chronic, hard to heal wounds. Chronic wounds ... amputation, lower leg wounds related to blood flow ... traumatic injury wounds which are complex and demonstrate ...
(Date:7/11/2014)... According to a new market ... (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - Global ... the global endoscopy devices market was valued at USD ... at a CAGR of 6.8% from 2013 to 2019, ... in 2019. Browse the full Endoscopy Devices Market ...
(Date:7/11/2014)... 11, 2014 Show ... & Health Expo 2014 were a brand ... London , plus a ...          (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a) ... )      (Photo: http://photos.prnewswire.com/prnh/20140711/696892-b ...
Breaking Medicine Technology:Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4
... , ... (OTC Bulletin Board: HFGB), a leading developer and producer,of plant ... food production in Xi,an, China, today reported that in its,third ... Revenues for the quarter ended Sept. ...
... , NORTH HOLLYWOOD, Calif., Nov. ... a leading national hospitalist physician group practice company, announced today that ... ACP Hospitalist as one of the 2009 Top Ten Hospitalists ... of the magazine. , Dr. Vaidyan has been a practicing physician ...
Cached Medicine Technology:Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 2Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 3Huifeng Bio-Pharmaceutical Technology Reports 26% Quarterly Revenue Increase 4IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3
(Date:7/14/2014)... July 14, 2014 This report ... market in Americas. The analysis includes market size ... period and key company share data by revenue ... Brazil and Mexico. It uses data and information ... and in-house analysis. , Scope, ...
(Date:7/14/2014)... Along with improving vision, cataract surgery may slow mental ... of dementia, a new study suggests. Better eyesight ... "These preliminary results indicate that improved vision can ... and their loved ones, both visual and non-visual," said ... University Hospitals Case Medical Center, in Ohio. Cataract ...
(Date:7/14/2014)... Kathleen Doheny HealthDay Reporter ... a spouse may be linked to multiple health issues, but ... For certain seniors, widowhood may even delay dementia, the ... problem, losing the spouse was associated with a later age ... said study researcher Dr. Bryan Woodruff. Woodruff, an ...
(Date:7/14/2014)... 2014 T.E.N., an information technology ... today that nominations will be accepted now through ... Executive® (ISE®) North America Awards. , Awards ... which recognizes executives who have made a positive ... protection, regulatory compliance, privacy and information security; and ...
(Date:7/14/2014)... 14, 2014 July 14, 2014 ... in enterprise-class cloud management, governance, and compliance software ... AvePoint software will be available to customers of ... , The hosting and value-added reseller ... following AvePoint solutions to new or existing customers: ...
Breaking Medicine News(10 mins):Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Cataract Surgery a Plus for Someone With Dementia, Study Says 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 2Health News:T.E.N. Accepting Nominations for the 2014 Information Security Executive® North America Awards 3Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 2Health News:AvePoint Works with Rackspace to Extend Vital Management Features to Hybrid SharePoint Deployments 3
... Guru Mashable.com Cites Organizations Using Social Media for Public Good ... The Oral Cancer Foundation was recently praised by a ... organizations that are effectively using Internet-based social media for the ... on Web 2.0 and social media such as blogs, Facebook, ...
... Counseling patients with non-alcoholic fatty liver disease (NAFLD) on how ... independent of changes in weight. These findings are in a ... a journal published by John Wiley & Sons on behalf ... (AASLD). The article is also available online at Wiley Interscience ...
... the bills were part of the Governor,s ,Prescription for Pennsylvania, ... Governor Edward G. Rendell today ceremonially signed three health care measures ... reform plan and a fourth that was originally proposed as part ... , "I,d like to recognize the good work of the ...
... ... websites inviting vivid personal stories about Internet dating and end-of-life dilemmas. Some stories will be ... director Robert Kenner. , ... (PRWEB) July 1, 2009 -- Kayce Freed Jennings, the wife of late ABC newsman Peter Jennings, ...
... herpes virus can cause inflammation, transplant rejection, study finds ... with herpes simplex virus who need a corneal transplant, ... outcomes, U.S. researchers say. , The cornea, which covers ... for vision, can be damaged when herpes simplex virus ...
... proposals and offer comment , , HARRISBURG, Pa., July ... on the Community Health Reinvestment Activities, also known and CHR, ... CHR plans are submitted to the Insurance Department by way ... known as Act 62 of 2008. , , ...
Cached Medicine News:Health News:Oral Cancer Foundation Praised for Its Social Media Efforts 2Health News:Exercise helps patients with non-alcoholic fatty liver disease 2Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 2Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 3Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 4Health News:Pennsylvania Governor Rendell Ceremonially Signs Four Health Care Bills That Will Reduce Costs, Improve Access and Quality 5Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 2Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 3Health News:First-Person Stories Gathered on Web Shape New Nonfiction TV Series from Veteran Producers 4Health News:Test Before Corneal Transplant May Improve Outcome 2Health News:Insurance Department Seeks Comment On Community Health Reinvestment Activities 2
... A surgically implanted bone growth stimulator ... EBI OsteoGen surgically implanted bone growth stimulator ... of nonunions when surgery is already planned ... concern. Because the OsteoGen is totally surgically ...
... contact between grant material and fracture ends ... bones., ,Grid-Like Format of Mesh Cathode Provides ... , ,The innovative Mesh Cathode of the ... and a scaffolding effect designed to increase ...
... Cystoscope System using EndoSheath Technology introduces ... urologists in both their hospitals and ... flexible cystoscope with the sterile, protective ... procedures, while minimizing the costs of ...
... Plasma-CISE™ (wire electrodes) and Plasma-CUT™ ... devices that produce precise, consistent ... spread and Vapor sealing of ... The devices provide excellent results ...
Medicine Products: